s6y NANOMIX Corp EFFECT

NANOMIX Corp EFFECT, filed Mar 15, 2013: primary_doc.xml

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: March 15, 2013
Accession Number: 0001102624-13-000344
Submission Type: POS AM
CIK: 0001473579
Company Name: Boston Therapeutics, Inc.
File Number: 333-184047